Background
- Proprotein Convertase Subtilisin/Kexin Type 9 inhibitors (PCSK9i) lower LDL-C and reduce ASCVD events, but their effects on circulating immune composition and cell-specific transcriptional programs remain incompletely defined.
Hypothesis:
PCSK9 inhibition is associated with changes in monocyte tra...
Maanas Gupta, S. Remala, K. Marks et al.· Circulation· 0 citations
Background:
Diabetes confers increased yet heterogeneous cardiovascular risk. Coronary microvascular dysfunction (CMD) is a robust, independent predictor of adverse outcomes and a key link between metabolic dysregulation and cardiovascular events. Excess visceral and ectopic adiposity, which are features of diabetes...
Carole Kounga, Filipe A. Moura, Lee Joseph et al.· Circulation· 0 citations
BACKGROUND
Left ventricular ejection fraction reserve (LVEF-R), defined as stress EF minus rest EF, is a marker for high-risk coronary artery disease in patients undergoing positron emission tomography myocardial perfusion imaging, but its prognostic and diagnostic significance in large real-world populations remains i...
W. Hijazi, Jian-Hang Zhou, Robert J. H. Miller et al.· Circulation Cardiovascular I...· 0 citations
A hypertensive response to exercise (HRE) has been associated with adverse cardiovascular (CV) outcomes in select populations, but its prognostic value in patients with normal myocardial perfusion remains unclear.
To evaluate whether HRE is associated with incident CV events in a low-risk exercise SPECT po...
J. Lu, S. Carre, J. Hainer et al.· European Heart Journal· 0 citations
AIMS
Inadequate pharmacologic stress may limit the diagnostic and prognostic accuracy of myocardial perfusion imaging (MPI). The splenic ratio (SR), a measure of stress adequacy, has emerged as a potential imaging biomarker. We developed an artificial intelligence (AI) method to derive SR and evaluated the prognostic v...
G. Ramirez, Naga L. Dharmavaram, A. Shanbhag et al.· Cardiovascular Research· 0 citations
Results support 124I-evuzamitide PET/CT as a diagnostic test to evaluate patients with suspected cardiac amyloidosis and support 124I-evuzamitide PET/CT as a diagnostic test to evaluate patients with suspected cardiac amyloidosis.
S. Dorbala, Mathew S. Maurer, S. Cuddy et al.· Journal of the American Medi...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.